- Others
- Wednesday, 08 Apr 2020
Massive U.S. fiscal response to nurse the economy through the coronavirus crisis
The U.S. government’s massive effort to nurse the economy through the coronavirus crisis was billed as a send-money-and-don’t-sweat-the-details flood of cash to people and businesses in a $22 trillion system that has ground to a halt.
So far, the checks are not in the mail.
From technological glitches to confusion over the fine points of policy, the delays are mounting. The federal government’s muddled response risks deepening and lengthening a recession already historic for the speed of its onset.
States are struggling to process a historic mountain of unemployment claims on outdated technology. Large corporations, including companies slammed by the “social distancing” edicts keeping people at home, remain in the dark on the details of promised loans. Small businesses by the millions are desperately seeking cash, while banks still lack the right paperwork days into a lending program.
The Federal Reserve, quick to throw a backstop here under large portions of the financial system and major corporations through open-ended bond purchases, has yet to complete a promised "Main Street" program of an all-encompassing safety net of credit.
Making matters worse, the original $2.3 trillion in aid that was passed by Congress late last month isn’t nearly enough, businesses warn.
Every day that passes without federal money getting to people is “an unnecessary hit to businesses and households across the U.S.,” said Gregory Daco, chief U.S. economist at Oxford Economics.
Related Industry Updates
North America Biopharmaceutical Contract Manufacturing Market 2020-2027| Types, Applications, Regional Analysis and Key Companies Involved are Lonza Group, Abbvie Inc,WuXi Biologics, Thermo Fisher Scientific
Oct 20, 2020
Trending Report on Canada Contrast Media Injectors Market 2027: size, production, prospects, consumption and cost structure | Nemoto Kyorindo, Bayer AG, GuerbetSA
Sep 01, 2020
North America Vaccines Market to See Tremendous Rise during 2019-2027 as Impacted by Covid-19| Sanofi, Johnson & Johnson, Merck & Co, VBI Vaccines
Sep 28, 2020
Tetra Bio-Pharma Announces $10.0 Million Bought Deal Offering
Jan 21, 2020
Oncology Nutrition: Foods, Tips, and Cancer Recovery Support
Mar 11, 2026
London Stocks Gain on Vaccine Hopes, GlaxoSmithKline Boost
Jul 15, 2020
Saudi Arabia will assist Yemen and Palestine in their fight against COVID-19
Apr 09, 2020